constitute an important and frequent cause of neonatal mortality/morbidity and long-term chronic handicaps. The mechanism by which normal neural tube fusion occurs is not known. The failure of rostral neural tube fusion seen in mouse embryos incubated in the presence of excess-D-glucose can be significantly prevented by the supplementation of myo-inositol to the culture medium. This protective effect of myo-inositol is reversed by indomethacin, an inhibitor of arachidonic acid metabolism leading to prostaglandin synthesis. Prostaglandin E2 added to the culture medium completely protects against the glucose-induced neural tube defect. These data suggest that the failure of neural tube fusion seen in diabetic embryopathy is mediated through a mechanism involving abnormalities in both the myo-inositol and arachidonic acid pathways, resulting in a functional deficiency of prostaglandins at a critical time of neural tube fusion.
Diabetic embryopathy, malformations in infants of diabetic women, represents a continued important complication of diabetes [1] . Serious congenital malformations, primarily involving the central nervous system and the heart, constitute the largest cause of death in the baby of the diabetic mother [2, 3] .
While several factors have been proposed as important in the mechanism producing diabetic embryopathy [4] [5] [6] [7] [8] [9] [10] , these hypotheses concerning diabetic embryopathy have, with some exceptions [11, 12] , tended to remain separate from those mechanisms involving abnormalities in intracellular myo-inositol (MI) and phosphatidylinositol metabolism which have been proposed for diabetic abnormalities in nerve, retina and kidney [13] [14] [15] [16] .
We have previously shown [17] that arachidonic acid supplementation significantly protects against glucose-induced failure of neural tube fusion in cultured mouse embryos. These observations suggested that the arachidonic acid cascade leading to prostaglandin synthesis may be critically involved in the process of normal neural tube fusion.
In this paper, we test whether MI and prostaglandins can reverse the glucose-induced inhibition of neural tube fusion, thus implying that abnormalities in both MI and prostaglandin pathways may play important roles in the mechanism of diabetic embryopathy.
Materials and methods
Mice of the highly inbred B10.A strain (B10.A/SgSnJ H-2aTla ~, The Jackson Laboratory Bar Harbor, ME, USA) were used for the MI and indomethacin studies. However, the serious fire at the Jackson Laboratory precluded continued use of this strain. Mice of the random bred CD-1 strain (Crl:CD-I(ICR) BR, Swiss; Charles River Breeding Laboratories Wilmington, MA, USA) were used for the prostaglandin experiments. Both strains show similar control rates of rostral neural tube fusion in the presence of L-glucose and identical inhibitory responses to D-glucose.
For these studies, D-and L-glucose were used in a concentration of 44 mmol/1. This concentration of D-glucose was chosen not because of any relevance to the glucose levels seen in human diabetic pregnancies, but because it causes rostral neural tube fusion to occur only one-third of the time and thus provides a clear background against which one can judge the protective effects of any intervention. L-glucose at 44 mmol/1 permits neural tube fusion in approximately three-fourths of the cultured embryos. Despite this significant difference in neural tube fusion with D-and L-glucose, growth of embryos, as measured by crown-rump length, is the same with either treatment. The increased number of neural tube malformations in medium containing D-glucose does not appear to be the result of growth delay. Both B10.A and CD-1 strains were maintained on a 12-h light cycle with the dark phase extending from 05.00 to 17.00 hours. Females were mated with syngeneic males from 10.00 to 16.00 hours. Presomite embryos (81/4 day B10.A, 8 day CD-1; plug day = day 0) were explanted and cultured using techniques described earlier [17] . The culture medium consisted of immediately-centrifuged, heatinactivated rat serum and 1% penicillin-streptomycin mixture (5000 I. U./gg each per ml; Flow Laboratories McLean, VA, USA). Additions to the culture medium were made at the expense of appropriate volumes of rat serum. Glucose (D-or L-) in distilled water was included as a 3% addition and MI in distilled water was included as a 2% addition. Indomethacin and the prostaglandins were solubilized in absolute ethanol and included as 0.33% and 0.1% additions, respectively. Controls received appropriate volumes of water and ethanol. The embryos were collected from culture at 48 h. The extraembryonic membranes (visceral yolk sac, amnion and ectoplacental cone) were removed and the rostral neural tube was determined to be either open or fused. Sadler et al. [18] identified several stages of rostral neural tube closure prior to fusion. To simplify presentation, all of these pre-fusion endpoints are grouped together as neural tube defects [10] and included in the open category. The embryonic heartbeat was used as a measure of viability.
Glucose (D-and L-), MI, indomethacin, and prostaglandins E2 (PGE2) and F2~ (PGF2~) were obtained from Sigma Chemical Company St. Louis, MO, USA. Carba-prostacyclin (cPGI2), the stable analogue of prostacyclin (PGI2), was purchased from Cayman Chemical Company Ann Arbor, MI, USA.
Statistical analysis
Statistical comparisons between groups were performed by the Pearson chi-square method; p-values > 0.05 were considered not significant (NS). Table i summarizes the results of the MI supplementation and the MI plus indomethacin experiments. Rostral neural tube fusion occurred significantly (p < 0.001) less frequently in embryos treated with D-glucose than in controls. When MI at a concentration of 4 mmol/1 was added to the D-glucose (44mmol/1) medium, a significant (p = 0.02) protective effect was seen when compared to Dglucose alone. However, this protective effect was also significantly (p < 0.01) different than the control and therefore incomplete. Lower (2 mmol/1) and higher (9 mmol/1)
Results
The protective effect of MI was reversed in experiments when indomethacin (140 gmol/1) was added to medium containing both D-glucose and the protective concentration of MI. Indomethacin permitted rostral neural tube fusion in only 28% of the embryos, a percentage statistically the same as D-glucose alone, but significantly different (p < 0.05) than D-glucose plus MI.
Since indomethacin at the concentration used is inhibitory at various sites in arachidonic acid mobilization and metabolism including the cyclooxygenase step [19] , the above data suggested that prostaglandins might be important in the process of neural tube fusion. Experiments were therefore carried out to test the effect of prostaglandins in reversing glucose-induced failure of neural tube fusion. The results are presented in Figure 1 . In these studies, fusion percentages for L-glucose controls were clearly higher than D-glucose-treated embryos (p <0.001). The addition to the D-glucose medium of PGE2 at a concentration of 142 nmol/1 completely protected the embryos against the failure of neural tube fusion seen in the presence of excess glucose (p = NS vs L-glucose controls and p < 0.02 vs D-glucose). PGE2 at 284 nmol/1 and cPGI2 at 143 nmol/1 and 285 nmol/1 partially, though not significantly, protected, and each of these prostaglandins at the highest concentration (2837 nmol/1 PGE2; 2835 nmol/1 cPGI2 was slightly more teratogenic than D-glucose alone. Low concentrations of PGE2 (28 nmol/1) and cPGI2 (29 nmol/1) did not afford protection against failure of neural tube fusion, PGF2~ was least potent. While 282 nmol/1 of PGF2~ was more effective than 141 nmol/1, neither concentration significantly reversed the failure of rostral neural tube fusion associ- 
Discussion
The supplementation of MI in suitable animal models has previously been shown to modify abnormalities caused by diabetes in peripheral nerve (decreased motor nerve conduction velocity [20] ), retina (decreased amplitude of the electroretinogram C-wave [21] ) and kidney (increased glomerular filtration rate [22] ). In the present study, the data demonstrate that supplemental MI exerts a significant protective effect against the teratogenic effects of a high glucose concentration on neural tube fusion. Specifically, the addition of MI to the mouse embryo cultured in the presence of excess D-glucose was associated with a significant, albeit incomplete, protection against failure of neural tube fusion. This protection against glucose-induced neural tube defects afforded by MI supplementation is consistent with data presented by Sussman and Matschinsky [23] , demonstrating that normal developmental MI increases are prevented in the neuroepithelium of embryos obtained from streptozotocin-induced diabetic rats. The concentration dependent effects of MI seen in our study are in accord with observations by Greene et al. [24] showing that MI supplementation ameliorates impaired motor nerve conduction velocity in diabetic rats only within a critical concentration range. The protection against glucose-related failure of neural tube fusion provided by supplementation of MI can be reversed when indomethacin, an inhibitor of arachidonic acid metabolism, is added to the experimental system. These studies were performed because we had previously published data to show that arachidonic acid supplementation significantly protected against glucose-induced failure of normal rostral neural tube fusion [17] . The suggestion that arachidonic acid was involved in neural tube fusion was confirmed by Pinter et al. [25] . In a subsequent paper [26] , this group once again confirmed that arachidonic acid protected against glucose-induced neural tube defects, but they were not able to document differences in the concentration of arachidonic acid between control and hyperglycaemia-treated whole embryos. This is perhaps not surprising, since a functional deficiency of arachidonic acid in one specific part of the embryo during neurulation (the head) may not be reflected in an overall change in its concentration in the whole embryo. Additionally, they measured arachidonic acid concentrations only at the end of the culture period and thereby may have missed specific but short-lived changes occurring during the critical time of neural tube fusion.
The reversal of the MI protective effect by indomethacin suggested that prostaglandins may play a specific role in neural tube fusion. This was tested directly by the addition to the culture medium of PGE2, PGF2~, and cPGI2. The choice of these prostaglandins was based on data demonstrating that PGE2, PGF2~ and 6-keto-PGFl~, the stable metabolite of prostacyclin (PGI2), are synthesized in cells from embryonic rats and mice [27, 28] and the em-595 bryonic ewe [29] . As shown in Figure 1 , PGE2 is most potent in affording protection; cPGI2 and PGFz~ only partially protect. The prostaglandin concentrations which are effective in these studies are within the normal working concentration range of prostaglandins in tissue culture media [30, 31] . The finding that high concentrations (> 2800 nmol/1) of the prostaglandins are teratogenic is consistent with the observation that prostaglandins injected during pregnancy can cause congenital malformations in mice [32] .
In summary, data are presented in this paper to document that MI supplementation in the mouse embryo culture system affords significant protection against glucoseinduced failure of rostral neural tube fusion. The protective effects of MI are reversed when indomethacin is placed in the culture medium in addition to D-glucose and MI. The indomethacin experiments suggest that prostaglandins may be involved in neural tube fusion. PGE2, used in a concentration which has been shown in other systems to elicit biological responses, completely protects against the glucose-related malformation. Taken together, the data are compatible with the hypothesis that the failure of rostral neural tube fusion seen in the mouse embryo culture system of diabetic embryopathy is mediated through a mechanism involving abnormalities in both the MI and arachidonic acid pathways, a result of which is a deficiency of prostaglandins at a critical time of neural tube fusion.
